Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5892065 | 0.82 | MEN1 (0.38) | MEN1HTTKMT2ATSHRALDH1A1 | |
| SCHEMBL14191853 | 0.79 | TSHR (0.48) | MEN1HTTKMT2ATSHRALDH1A1 | |
| SCHEMBL10444028 | 0.79 | LTA4H (0.46) | TSHRALDH1A1LTA4H | |
| SCHEMBL1953867 | 0.78 | ALDH1A1 (0.40) | MEN1HTTKMT2ATSHRALDH1A1 | |
| SCHEMBL6655637 | 0.78 | ALDH1A1 (0.40) | MEN1HTTKMT2ATSHRALDH1A1 | |
| SCHEMBL27824747 | 0.77 | CHRM5 (0.50) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL28228689 | 0.77 | APP (0.41) | MEN1HTTKMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL21484985 | 0.77 | TSHR (0.46) | HTTTSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL28084405 | 0.76 | ALDH1A1 (0.37) | MEN1HTTKMT2ATSHRALDH1A1 | |
| SCHEMBL10358899 | 0.74 | ALDH1A1 (0.38) | MEN1HTTKMT2ATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103495340-B | The method of SOx in compound alcamines solution removal gas | BEIJING BOYUAN HENGSHENG HIGH-TECHNOLOGY CO.,LTD. (CN) | 2015-11-18 | — | — | CN | claimed |
| CN-103495340-A | Method of removing SOx in gas by compound alkanolamine solution | BEIJING BOYUAN HENGSHENG HIGH TECHNOLOGY CO LTD | 2014-01-08 | — | — | CN | claimed |
| CN-101915760-B | Method for detecting cysteine content in real time by colorimetric method | UNIV DONGHUA | 2013-10-09 | — | — | CN | claimed |
| CN-102337668-B | Manufacture method of washable polyaniline/terylene composite conductive fabric | SUZHOU XINLUN CLEAN TECHNOLOGY CO LTD | 2013-03-20 | — | — | CN | claimed |
| CN-102337668-A | Washable polyaniline/terylene composite conductive fabric and manufacture method thereof | SUZHOU XINLUN CLEAN TECHNOLOGY CO LTD | 2012-02-01 | — | — | CN | claimed |
| CN-101915760-A | Method for detecting cysteine content in real time by colorimetric method | UNIV DONGHUA | 2010-12-15 | — | — | CN | claimed |
| CN-1251759-C | Biological degradable injectable bracket of modified hydrogel for use in cartilage tissue engineering | UNIV TSINGHUA (CN) | 2006-04-19 | — | — | CN | claimed |
| CN-1539385-A | Biological degradable injectable bracket of modified hydrogel for use in cartilage tissue engineering | 清华大学 | 2004-10-27 | — | — | CN | claimed |
| CN-111748214-A | Antibacterial ABS plastic preparation process | 田虹 | 2020-10-09 | — | — | CN | disclosed |
| CN-109715583-A | Bi-component plaster material and application thereof | 喜利得股份公司 | 2019-05-03 | — | — | CN | disclosed |
| US-20170183369-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2017-06-29 | — | — | US | disclosed |
| US-20170107241-A1 | SALEN COMPLEXES WITH DIANIONIC COUNTERIONS | NOVOMER, INC. (US) | 2017-04-20 | — | — | US | disclosed |
| US-20170080409-A1 | CATALYSTS FOR EPOXIDE CARBONYLATION | NOVOMER, INC. (US) | 2017-03-23 | — | — | US | disclosed |
| US-9505878-B2 | Catalysts and methods for polymer synthesis | NOVOMER, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| CN-101915760-A | Method for detecting cysteine content in real time by colorimetric method | UNIV DONGHUA | 2010-12-15 | — | — | CN | disclosed |
| CN-1251759-C | Biological degradable injectable bracket of modified hydrogel for use in cartilage tissue engineering | UNIV TSINGHUA (CN) | 2006-04-19 | — | — | CN | disclosed |
| CN-1539385-A | Biological degradable injectable bracket of modified hydrogel for use in cartilage tissue engineering | 清华大学 | 2004-10-27 | — | — | CN | disclosed |
| EP-0361230-B1 | Mixtures from polyamides, aromatic polycarbonates and maleic imide copolymeres and use of them as thermoplastic moulding compositions | BAYER AG (DE) | 1994-01-12 | — | — | EP | disclosed |
| EP-0361230-A2 | Mixtures from polyamides, aromatic polycarbonates and maleic imide copolymeres and use of them as thermoplastic moulding compositions | BAYER AG (DE) | 1990-04-04 | — | — | EP | disclosed |
| US-4076849-A | AROMATIC SECONDARY AMINES | CANADA PACKERS LIMITED (CA) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170107241-A1 | SALEN COMPLEXES WITH DIANIONIC COUNTERIONS | NCLN, POLN, NCL | MEN1 942/4885HTT 402/4885KMT2A 3824/4885 |
| US-20170183369-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | MEN1 3240/4885HTT 4598/4885KMT2A 1825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.